• Research Groups

About

Durval Costa Lab

Durval Costa Lab

The clinical use of radiopharmaceuticals for SPECT (Single Photon Emission Computed Tomography) and PET (Positron Emission Tomography) is based on the pharmacodynamics and pharmacokinetics properties of radionuclide labelled molecules. The cellular and sub-cellular specific binding of radiopharmaceuticals helps in the diagnosis and therapy of several diseases by identifying the functional abnormality within tissues and cells. SPECT and PET imaging processing and analysis are crucial to obtain meaningful and quantitative data to classify disease stages and assess response to therapy regimens. Our team is dedicated to develop and use new radiopharmaceuticals, to improve radiation dosimetry incumbent to the use of internal radiation sources and to improve processing and analysis by developing software to classify and quantify disease due to cellular functional abnormalities.

INFO

Opportunities

If you are interested in joining our group, please contact Durval Costa via email.

Team

Durval Costa Lab

Know our Team

Durval Costa

Principal Investigator

Ana Canudo

Technician

Ana Capacho

Pharmacist

Ângelo Silva

Nuc. Med. Physician

Bárbara Freitas

Technician

Carla Oliveira

Nuc. Med. Physician

Cláudia Constantino

Student

Francisco Oliveira

Mathematician

Helena Delgado

Technician

Joana Castanheira

Nuc. Med. Physician

Juliana Correia

Technician

Marisa Machado

Technician

Miguel Andrade

Technician

Paulo Ferreira

Physicist

Rita Oliveira

Technician

Rui Parafita

Physicist

Sandra Chaves

Technician

Sílvia Almeida

Researcher

Sofia Vaz

Nuc. Med. Physician

Sónia Teixeira

Technician

Publications

Durval Costa Lab

Loading
Por favor aguarde...